Items where authors include "Campbell, D."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Steinberg, S., Hughes, S., Hui, H. et al. (59 more authors) (2024) Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: a systematic review and meta-analysis. International Journal of Cancer, 154 (8). pp. 1394-1412. ISSN 0020-7136

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Petzold, J., Hawxwell, T., Jantke, K. et al. (27 more authors) (2023) A global assessment of actors and their roles in climate change adaptation. Nature Climate Change, 13. pp. 1250-1257. ISSN 1758-678X

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Simpson, N.P., Williams, P.A., Mach, K.J. et al. (16 more authors) (2023) Adaptation to compound climate risks: A systematic global stocktake. iScience, 26 (2). 105926. ISSN 2589-0042

Flume, P.A., Biner, R.F., Downey, D.G. et al. (190 more authors) (2021) Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study. The Lancet Respiratory Medicine, 9 (7). pp. 733-746. ISSN 2213-2600

Gibani, M.M., Jin, C., Shrestha, S. et al. (22 more authors) (2020) Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model. PLOS Neglected Tropical Diseases, 14 (10). e0008783. ISSN 1935-2727

Oguti, B., Gibani, M., Darlow, C. et al. (7 more authors) (2019) Factors influencing participation in controlled human infection models : a pooled analysis from six enteric fever studies [under peer review]. Wellcome Open Research, 4. 153.

Church, K., Campbell, D. and Halliday, V. orcid.org/0000-0003-2458-5253 (2019) Impact of hospitalisation of children on parental dietary habits: a qualitative study. Archives of Disease in Childhood, 104 (10). pp. 967-971. ISSN 0003-9888

Dobinson, H.C., Gibani, M.M., Jones, C. et al. (21 more authors) (2017) Evaluation of the clinical and microbiological response to Salmonella Paratyphi A infection in the first paratyphoid human challenge model. Clinical Infectious Diseases. ISSN 1058-4838

McCullagh, D., Dobinson, H.C., Darton, T. et al. (10 more authors) (2015) Understanding paratyphoid infection: study protocol for the development of a human model of Salmonella enterica serovar Paratyphi A challenge in healthy adult volunteers. BMJ Open, 5. e007481. - . ISSN 2044-6055